13F HOLDINGS REPORT
COMMODORE CAPITAL LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001831942-24-000006
Total Value
$1.50B
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 4,360,000 | $196.3M | 13.13% |
| 2 | VERA THERAPEUTICS INC | VERA | 3,165,000 | $136.5M | 9.13% |
| 3 | NUVALENT INC | NUVL | 1,487,756 | $111.7M | 7.47% |
| 4 | XENON PHARMACEUTICALS INC | XENE | 2,167,793 | $93.3M | 6.24% |
| 5 | SPYRE THERAPEUTICS INC | SYRE | 1,884,084 | $71.5M | 4.78% |
| 6 | ENLIVEN THERAPEUTICS INC | ELVN | 3,973,245 | $69.9M | 4.67% |
| 7 | VAXCYTE INC | PCVX | 860,000 | $58.7M | 3.93% |
| 8 | MIND MEDICINE MINDMED INC | 60255C885 | 5,833,333 | $54.8M | 3.67% |
| 9 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 1,375,000 | $54.5M | 3.64% |
| 10 | ARVINAS INC | ARVN | 1,275,000 | $52.6M | 3.52% |
| 11 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,050,000 | $45.5M | 3.04% |
| 12 | COGENT BIOSCIENCES INC | COGT | 6,425,000 | $43.2M | 2.89% |
| 13 | PHARVARIS N V | PHVS | 1,725,000 | $39.9M | 2.67% |
| 14 | CELLDEX THERAPEUTICS INC NEW | CLDX | 866,468 | $36.4M | 2.43% |
| 15 | NKARTA INC | NKTX | 3,165,000 | $34.2M | 2.29% |
| 16 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,934,653 | $33.9M | 2.27% |
| 17 | CELCUITY INC | CELC | 1,555,954 | $33.6M | 2.25% |
| 18 | KURA ONCOLOGY INC | KURA | 1,525,000 | $32.5M | 2.18% |
| 19 | C4 THERAPEUTICS INC | CCCC | 3,410,384 | $27.9M | 1.86% |
| 20 | ORIC PHARMACEUTICALS INC | ORIC | 2,000,000 | $27.5M | 1.84% |
| 21 | ABIVAX SA | AAVXF | 1,895,003 | $27.1M | 1.81% |
| 22 | PERSPECTIVE THERAPEUTICS INC | CATX | 21,052,631 | $25.1M | 1.68% |
| 23 | IMMUNOVANT INC | IMVT | 750,990 | $24.3M | 1.62% |
| 24 | KYVERNA THERAPEUTICS INC | KYTX | 912,189 | $22.7M | 1.52% |
| 25 | ENGENE HOLDINGS INC | ENGNW | 1,250,000 | $21.2M | 1.42% |
| 26 | APOGEE THERAPEUTICS INC | APGE | 290,000 | $19.3M | 1.29% |
| 27 | CABALETTA BIO INC | CABA | 1,100,000 | $18.8M | 1.25% |
| 28 | AUTOLUS THERAPEUTICS PLC | AUTL | 2,300,000 | $14.7M | 0.98% |
| 29 | THIRD HARMONIC BIO INC | 88427A107 | 1,250,000 | $11.8M | 0.79% |
| 30 | NEUROGENE INC | NGNE | 200,000 | $10.2M | 0.68% |
| 31 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 657,333 | $9.3M | 0.62% |
| 32 | VISTAGEN THERAPEUTICS INC | VTGN | 1,575,000 | $8.3M | 0.56% |
| 33 | SYNDAX PHARMACEUTICALS INC | SNDX | 318,851 | $7.6M | 0.51% |
| 34 | SOLENO THERAPEUTICS INC | SLNO | 169,533 | $7.3M | 0.49% |
| 35 | HELIX ACQUISITION CORP II | HLXC | 500,000 | $5.2M | 0.35% |
| 36 | MACROGENICS INC | MGNX | 295,020 | $4.3M | 0.29% |
| 37 | ADICET BIO INC | ACET | 1,374,320 | $3.2M | 0.22% |
| 38 | SAB BIOTHERAPEUTICS INC | SABSW | 183,174 | $831,610 | 0.06% |
| 39 | DBV TECHNOLOGIES S A | DBVTF | 92,687 | $69,432 | 0.00% |